Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug 5;5(8):e169.
doi: 10.1371/journal.pmed.0050169.

Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières

Jean-Paul Guthmann  1 , Francesco Checchi, Ingrid van den Broek, Suna Balkan, Michel van Herp, Eric Comte, Oscar Bernal, Jean-Marie Kindermans, Sarah Venis, Dominique Legros, Philippe J Guerin
Affiliations

Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières

Jean-Paul Guthmann et al. PLoS Med. .

Abstract

Jean-Paul Guthmann and colleagues describe the output of MSF's work in antimalarial efficacy assessment during the last decade.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow Chart of Sites and Type of MSF Pf Efficacy Studies, 1996–2004
Figure 2
Figure 2. Number of MSF Pf Efficacy Studies and Treatment Groups (Monotherapies and ACT) Per Year of Completion, 1996–2004
Cells with X represent studies of 14-day follow-up or less; empty cells represent studies of 28-day follow-up or more. Mono = monotherapies.
See this image and copyright information in PMC

References

    1. Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001;64 (1–2 Suppl):12–17. - PubMed
    1. Zucker JR, Ruebush TK, II, Obonyo C, Otieno J, Campbell C. The mortality consequences of the continued use of chloroquine in Africa: Experience in Siaya, Western Kenya. Am J Trop Med Hyg. 2003;68:386–390. - PubMed
    1. White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, et al. Averting a malaria disaster. Lancet. 1999;353:1965–1967. - PubMed
    1. World Health Organization. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. 1996. Available: http://www.who.int/drugresistance/malaria/en/Assessment_malaria_96.pdf. Accessed 7 July 2008.
    1. World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. 2003. Available: http://www.who.int/malaria/docs/ProtocolWHO.pdf. Accessed 7 July 2008.

Publication types